Gal-3 protein expression was upregulated in hearts of HFD rats, and MCP treatment reduced the increase in total cardiac collagen content without modifying either body weight or cardiac hypertrophy (Martinez-Martinez et al., 2015b). This evidence concerns the gene LGALS3 and cardiac hypertrophy.